These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35285458)

  • 1. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
    Abouhashem NS; Elwan A; Elaidy NF
    Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
    BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
    J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
    Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
    Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
    Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC
    PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
    Nathan CO; Liu L; Li BD; Abreo FW; Nandy I; De Benedetti A
    Oncogene; 1997 Jul; 15(5):579-84. PubMed ID: 9247311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.
    Singh J; Jayaraj R; Baxi S; Mileva M; Skinner J; Dhand NK; Thomas M
    Mol Clin Oncol; 2016 Feb; 4(2):166-172. PubMed ID: 26893854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
    Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
    Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
    Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
    J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer.
    Fury MG; Lee NY; Sherman E; Ho AL; Rao S; Heguy A; Shen R; Korte S; Lisa D; Ganly I; Patel S; Wong RJ; Shaha A; Shah J; Haque S; Katabi N; Pfister DG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):479-86. PubMed ID: 24074921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
    Sorrells DL; Meschonat C; Black D; Li BD
    J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO; Sanders K; Abreo FW; Nassar R; Glass J
    Cancer Res; 2000 Jul; 60(13):3599-604. PubMed ID: 10910074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Surgical Margin Distance With Survival in Patients With Resected Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
    Sunkara PR; Graff JT; Cramer JD
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):317-326. PubMed ID: 36821132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
    Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
    Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.